In the News
As Seen In: Pharmaceutical Commerce
Q&A: How direct access and transparency close the patient gap
For decades, pharmaceutical companies have relied on a complex network of intermediaries to help patients access medications. But…
As Seen In: Pharmaceutical Executive
Modernizing market access and patient support services: Q&A with Cam Olig
New survey highlights growing demand for better patient access.
More direct ways of selling and buying prescription drugs was the talk at Asembia
At this year’s Asembia Specialty Pharmacy Summit, one theme stood out: the growing momentum behind more direct ways…
As Seen In: Authority Magazine
Chief Executive Officer Chris Blackley on the healthcare leadership operating system
“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…
As Seen In: SHRM
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.
As Seen In: EBN
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
As Seen In: Reuters
Data shows US advertising spend increasing for pharma manufacturers
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
As Seen In: HIT Consultant
Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence
Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…
As Seen In: EBN
A broker’s guide to breaking the rebate cycle
Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…
As Seen In: Drug Topics
Navigating GLP-1 access & complexity: 4 key insights
Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…
As Seen In: BenefitsPRO
Could voluntary prescription plans help small employers ease the squeeze?
As healthcare costs continue to burden small businesses, voluntary prescription plans could be a compelling solution for employers…
As Seen In: BenefitsPRO
With tariffs in the mix, pharmacy benefits deserve a second look
Prescryptive’s SVP of Payer Solutions, Rae McMahan, offers timely insights in her new article in BenefitsPRO, “With tariffs in…